LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma

LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma

Bibliographic Details
Main Authors:	Giotopoulou, G, Krontira, A, Spiropoulou, N, Tourkochristou, E, Kanellakis, N, Lilis, I, Marazioti, A, Spella, M, Stathopoulos, G
Format:	Conference item
Published:	European Respiratory Society 2017

Similar Items

cAMP-response element binding protein in KRAS-driven lung adenocarcinoma
by: Giotopoulou, G, et al.
Published: (2016)

LSC Abstract – Host-environmental IL-1b drives mutant KRAS-IKKa addiction in malignant pleural effusion
by: Marazioti, A, et al.
Published: (2016)

IκB Kinase α is required for development and progression of KRAS-mutant lung adenocarcinoma
by: Vreka, M, et al.
Published: (2018)

LSC-2017-Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
by: Kanellakis, N, et al.
Published: (2017)

Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma
by: Ioannis Lilis, et al.
Published: (2019-07-01)

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
by: Marazioti, A, et al.
Published: (2018)

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
by: Antonia Marazioti, et al.
Published: (2018-02-01)

Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis
by: Giopanou, I, et al.
Published: (2016)

LSC Abstract – Osteopontin as an airway epithelial tumor promoter
by: Psallidas, I, et al.
Published: (2016)

S7 Mouse lung adenocarcinoma cell lines reveal PRL2C2 as a novel lung tumour promoter
by: Kanellakis, N, et al.
Published: (2016)

Mutant KRAS promotes malignant pleural effusion formation
by: Αgalioti, T, et al.
Published: (2017)

Mutant KRAS promotes malignant pleural effusion formation
by: Theodora Agalioti, et al.
Published: (2017-05-01)

NRAS destines tumor cells to the lungs
by: Giannou, AD, et al.
Published: (2017)

Immune Resistance in Lung Adenocarcinoma
by: Magda Spella, et al.
Published: (2021-01-01)

Shared epithelial pathways to lung repair and disease
by: Magda Spella, et al.
Published: (2017-06-01)

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
by: Kaja Kostyrko, et al.
Published: (2023-07-01)

KRAS signaling in malignant pleural mesothelioma
by: Antonia Marazioti, et al.
Published: (2022-02-01)

Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
by: Ioanna Giopanou, et al.
Published: (2015-01-01)

Club cells form lung adenocarcinomas and maintain the alveoli of adult mice
by: Spella, M, et al.
Published: (2019)

RAS oncogenes direct metastasis
by: Magda Spella, et al.
Published: (2017-09-01)

Having the Conversation: The 2011 LSC Colloquium
by: Michael A. Crumpton
Published: (2011-12-01)

Early Career Members at the ERS LSC 2017: mechanistic overlap between chronic lung injury and cancer
by: Isaac Almendros, et al.
Published: (2017-12-01)

KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy
by: Pinto Rosamaria, et al.
Published: (2019-08-01)

Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma
by: Sarah Neidler, et al.
Published: (2019-04-01)

Club cells form lung adenocarcinomas and maintain the alveoli of adult mice
by: Magda Spella, et al.
Published: (2019-05-01)

Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways
by: Kanellakis, N, et al.
Published: (2016)

Titanium and Stainless Steel MIG LSC Welding
by: Poláková Nela, et al.
Published: (2019-06-01)

IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells
by: Felipe Silva Rodrigues, et al.
Published: (2020-08-01)

Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma
by: Politi, Katerina, et al.
Published: (2017)

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
by: Elisa Baldelli, et al.
Published: (2021-09-01)

Non-Oncogene Addiction of <i>KRAS</i>-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ
by: Magda Spella, et al.
Published: (2023-03-01)

GOCE Downward Continuation to the Earth’s Surface and Improvements to Local Geoid Modeling by FFT and LSC
by: Dimitrios A. Natsiopoulos, et al.
Published: (2023-02-01)

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
by: William Pao, et al.
Published: (2005-01-01)

P438: ARYL HYDROCARBON RECEPTOR SIGNALLING IN NORMAL HAEMATOPOIETIC (HSC) AND LEUKEMIA STEM CELLS (LSC): DIFFERENTIAL EFFECT OF AHR ANTAGONIST ON LSC COMPARED TO HSC
by: A. Oryshchuk, et al.
Published: (2022-06-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

An In Vivo Inflammatory Loop Potentiates KRAS Blockade
by: Kristina A. M. Arendt, et al.
Published: (2022-03-01)

Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
by: Marina Salmón, et al.
Published: (2023-04-01)

Nf1 loss promotes Kras‐driven lung adenocarcinoma and results in Psat1‐mediated glutamate dependence
by: Xiaojing Wang, et al.
Published: (2019-06-01)

KRAS<sup>G12C</sup> Can Either Promote or Impair Cap-Dependent Translation in Two Different Lung Adenocarcinoma Cell Lines
by: George Kyriakopoulos, et al.
Published: (2021-02-01)

Radon Mitigation Applications at the Laboratorio Subterráneo de Canfranc (LSC)
by: Javier Pérez-Pérez, et al.
Published: (2022-02-01)